Epirizole

DB08991

small molecule experimental

Deskripsi

Epirizole is an oral nonsteroidal anti-inflammatory drug (NSAID) used for muscle and joint pain.

Struktur Molekul 2D

Berat 234.2545
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1386 Data
Amlodipine Epirizole may decrease the antihypertensive activities of Amlodipine.
Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Epirizole.
Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Epirizole.
Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Epirizole.
Isoetharine The risk or severity of hypertension can be increased when Isoetharine is combined with Epirizole.
Ziprasidone The risk or severity of hypertension can be increased when Ziprasidone is combined with Epirizole.
Methysergide The risk or severity of hypertension can be increased when Methysergide is combined with Epirizole.
Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Epirizole.
Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Epirizole.
Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Epirizole.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Epirizole.
Norepinephrine The risk or severity of hypertension can be increased when Norepinephrine is combined with Epirizole.
Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Epirizole.
Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Epirizole.
Phenylpropanolamine The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Epirizole.
Promazine The risk or severity of hypertension can be increased when Promazine is combined with Epirizole.
Droperidol The risk or severity of hypertension can be increased when Droperidol is combined with Epirizole.
Doxapram The risk or severity of hypertension can be increased when Doxapram is combined with Epirizole.
Atropine The risk or severity of hypertension can be increased when Atropine is combined with Epirizole.
Lisuride The risk or severity of hypertension can be increased when Lisuride is combined with Epirizole.
Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Epirizole.
Metaraminol The risk or severity of hypertension can be increased when Metaraminol is combined with Epirizole.
Furazolidone The risk or severity of hypertension can be increased when Furazolidone is combined with Epirizole.
Epinephrine The risk or severity of hypertension can be increased when Epinephrine is combined with Epirizole.
Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Epirizole.
Ergotamine The risk or severity of hypertension can be increased when Ergotamine is combined with Epirizole.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Epirizole.
Sufentanil The risk or severity of hypertension can be increased when Sufentanil is combined with Epirizole.
Methoxamine The risk or severity of hypertension can be increased when Methoxamine is combined with Epirizole.
Risperidone The risk or severity of hypertension can be increased when Risperidone is combined with Epirizole.
Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Epirizole.
Isoflurane The risk or severity of hypertension can be increased when Isoflurane is combined with Epirizole.
Propiomazine The risk or severity of hypertension can be increased when Propiomazine is combined with Epirizole.
Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Epirizole.
Minaprine The risk or severity of hypertension can be increased when Minaprine is combined with Epirizole.
Orciprenaline The risk or severity of hypertension can be increased when Orciprenaline is combined with Epirizole.
Propofol The risk or severity of hypertension can be increased when Propofol is combined with Epirizole.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Epirizole.
Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Epirizole.
Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Epirizole.
Benzphetamine The risk or severity of hypertension can be increased when Benzphetamine is combined with Epirizole.
Ritodrine The risk or severity of hypertension can be increased when Ritodrine is combined with Epirizole.
Flupentixol The risk or severity of hypertension can be increased when Flupentixol is combined with Epirizole.
Remifentanil The risk or severity of hypertension can be increased when Remifentanil is combined with Epirizole.
Bitolterol The risk or severity of hypertension can be increased when Bitolterol is combined with Epirizole.
Oxymetazoline The risk or severity of hypertension can be increased when Oxymetazoline is combined with Epirizole.
Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Epirizole.
Salmeterol The risk or severity of hypertension can be increased when Salmeterol is combined with Epirizole.
Naratriptan The risk or severity of hypertension can be increased when Naratriptan is combined with Epirizole.
Formoterol The risk or severity of hypertension can be increased when Formoterol is combined with Epirizole.
Frovatriptan The risk or severity of hypertension can be increased when Frovatriptan is combined with Epirizole.
Methoxyflurane The risk or severity of hypertension can be increased when Methoxyflurane is combined with Epirizole.
Selegiline The risk or severity of hypertension can be increased when Selegiline is combined with Epirizole.
Ergoloid mesylate The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Epirizole.
Isoprenaline The risk or severity of hypertension can be increased when Isoprenaline is combined with Epirizole.
Arbutamine The risk or severity of hypertension can be increased when Arbutamine is combined with Epirizole.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Epirizole.
Halothane The risk or severity of hypertension can be increased when Halothane is combined with Epirizole.
Moclobemide The risk or severity of hypertension can be increased when Moclobemide is combined with Epirizole.
Pergolide The risk or severity of hypertension can be increased when Pergolide is combined with Epirizole.
Desflurane The risk or severity of hypertension can be increased when Desflurane is combined with Epirizole.
Bromocriptine The risk or severity of hypertension can be increased when Bromocriptine is combined with Epirizole.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Epirizole.
Aripiprazole The risk or severity of hypertension can be increased when Aripiprazole is combined with Epirizole.
Isocarboxazid The risk or severity of hypertension can be increased when Isocarboxazid is combined with Epirizole.
Ergometrine The risk or severity of hypertension can be increased when Ergometrine is combined with Epirizole.
Lisdexamfetamine The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Epirizole.
Fenoterol The risk or severity of hypertension can be increased when Fenoterol is combined with Epirizole.
Pirbuterol The risk or severity of hypertension can be increased when Pirbuterol is combined with Epirizole.
Ephedra sinica root The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Epirizole.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Epirizole.
Mephentermine The risk or severity of hypertension can be increased when Mephentermine is combined with Epirizole.
Procaterol The risk or severity of hypertension can be increased when Procaterol is combined with Epirizole.
Yohimbine The risk or severity of hypertension can be increased when Yohimbine is combined with Epirizole.
Methotrimeprazine The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Epirizole.
Clenbuterol The risk or severity of hypertension can be increased when Clenbuterol is combined with Epirizole.
Bambuterol The risk or severity of hypertension can be increased when Bambuterol is combined with Epirizole.
MMDA The risk or severity of hypertension can be increased when MMDA is combined with Epirizole.
Midomafetamine The risk or severity of hypertension can be increased when Midomafetamine is combined with Epirizole.
2,5-Dimethoxy-4-ethylamphetamine The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Epirizole.
4-Methoxyamphetamine The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Epirizole.
4-Bromo-2,5-dimethoxyamphetamine The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Epirizole.
Tenamfetamine The risk or severity of hypertension can be increased when Tenamfetamine is combined with Epirizole.
Chlorphentermine The risk or severity of hypertension can be increased when Chlorphentermine is combined with Epirizole.
Dextroamphetamine The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Epirizole.
Phendimetrazine The risk or severity of hypertension can be increased when Phendimetrazine is combined with Epirizole.
Solifenacin The risk or severity of hypertension can be increased when Solifenacin is combined with Epirizole.
Periciazine The risk or severity of hypertension can be increased when Periciazine is combined with Epirizole.
Acepromazine The risk or severity of hypertension can be increased when Acepromazine is combined with Epirizole.
Thioproperazine The risk or severity of hypertension can be increased when Thioproperazine is combined with Epirizole.
Zuclopenthixol The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Epirizole.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Epirizole.
Clorgiline The risk or severity of hypertension can be increased when Clorgiline is combined with Epirizole.
1-benzylimidazole The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Epirizole.
Iproniazid The risk or severity of hypertension can be increased when Iproniazid is combined with Epirizole.
Nialamide The risk or severity of hypertension can be increased when Nialamide is combined with Epirizole.
Lysergic acid diethylamide The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Epirizole.
Dronedarone The risk or severity of hypertension can be increased when Dronedarone is combined with Epirizole.
Flibanserin The risk or severity of hypertension can be increased when Flibanserin is combined with Epirizole.
Iloperidone The risk or severity of hypertension can be increased when Iloperidone is combined with Epirizole.

Referensi & Sumber

Synthesis reference: South African Patent Application 67/4936; January 19, 1968; assigned to Daiichi Seiyaku Company Limited, Japan.

Contoh Produk & Brand

Produk: 0 • International brands: 2
International Brands
  • Karmarte — Toho
  • Mebron — Daiichi Sankyo

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul